List of works - Tatiana R. Rosenstock

Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.

scientific article published on 20 May 2014

Bax affects intracellular Ca2+ stores and induces Ca2+ wave propagation

scientific article published in December 2004

CD36 is expressed in a defined subpopulation of neurons in the olfactory epithelium.

scientific article

Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models

scientific article

Current therapeutic advances in patients and experimental models of Huntington's disease.

scientific article published on March 2014

Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research

scientific article published on 25 August 2020

Dysregulation of autophagy as a common mechanism in lysosomal storage diseases.

scientific article published on 12 December 2017

Evaluation of some cell death features by real time real space microscopy

scientific article published in January 2008

FK506 ameliorates cell death features in Huntington's disease striatal cell models.

scientific article published on 15 June 2011

Gene Expression Control by Glucocorticoid Receptors during Innate Immune Responses

scientific article

Glutamate-induced alterations in Ca2+ signaling are modulated by mitochondrial Ca2+ handling capacity in brain slices of R6/1 transgenic mice.

scientific article published on July 2010

Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.

scientific article published on 14 September 2012

Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.

scientific article published on 25 January 2017

In Vitro Screening Platforms for Identifying Autophagy Modulators in Mammalian Cells

scientific article published on 01 January 2019

Increase in bax expression and apoptosis are associated in Huntington's disease progression

scientific article published on 27 March 2008

Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells

scientific article published on 30 June 2014

Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.

scientific article published on 03 February 2016

Mitochondrial Dysfunction and Changes in High-Energy Compounds in Different Cellular Models Associated to Hypoxia: Implication to Schizophrenia

scientific article published on 02 December 2019

Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid

scientific article published in March 2004

Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid

scientific article published on 15 August 2008

Selfish brain and selfish immune system interplay: A theoretical framework for metabolic comorbidities of mood disorders

scientific article published on 18 November 2016

List of works by Tatiana R. Rosenstock

Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.

Bax affects intracellular Ca2+ stores and induces Ca2+ wave propagation

CD36 is expressed in a defined subpopulation of neurons in the olfactory epithelium.

Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models

Current therapeutic advances in patients and experimental models of Huntington's disease.

Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research

Dysregulation of autophagy as a common mechanism in lysosomal storage diseases.

Evaluation of some cell death features by real time real space microscopy

FK506 ameliorates cell death features in Huntington's disease striatal cell models.

Gene Expression Control by Glucocorticoid Receptors during Innate Immune Responses

Glutamate-induced alterations in Ca2+ signaling are modulated by mitochondrial Ca2+ handling capacity in brain slices of R6/1 transgenic mice.

Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.

Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.

In Vitro Screening Platforms for Identifying Autophagy Modulators in Mammalian Cells

Increase in bax expression and apoptosis are associated in Huntington's disease progression

Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells

Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.

Mitochondrial Dysfunction and Changes in High-Energy Compounds in Different Cellular Models Associated to Hypoxia: Implication to Schizophrenia

Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid

Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid

Selfish brain and selfish immune system interplay: A theoretical framework for metabolic comorbidities of mood disorders